세계의 의약품용 젤라틴 시장 규모 및 예측 : 유형별, 용도별, 공급원별, 지역별 분석(2023-2030년)

Global Pharmaceutical Gelatin Market is valued at approximately USD 1.21 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2023-2030. Pharmaceutical Gelatin is a protein derived from collagen, typically obtained from animal sources such as bones, skin, and connective tissues. It is commonly used as a key ingredient in the production of various pharmaceutical products, including capsules, soft gels, tablets, and other dosage forms. The Pharmaceutical Gelatin market is expanding because of factors such as the growing prevalence of chronic illnesses and the expansion of the pharmaceutical industry. Pharmaceutical Gelatin's ability to form a stable gel matrix makes it suitable for encapsulating and delivering medications orally. As a result, the demand for Pharmaceutical Gelatin has progressively increased in the international market during the forecast period 2023-2030.

Patients with chronic illnesses often require long-term medication regimens. Gelatin-based capsules and soft gels are preferred by many patients due to their ease of swallowing, smooth texture, and taste-masking capabilities. Improved patient compliance and adherence to prescribed medication regimens can contribute to better management of chronic conditions, further driving the demand for gelatin-based pharmaceutical products. According to the United Nations report, chronic diseases are anticipated to account for 70% of all global fatalities, while the global disease burden will be 56% by the year 2030. The most significant growth is expected in the African and Eastern Mediterranean regions. Furthermore, gelatin is a versatile excipient that can be used in various pharmaceutical formulations due to its unique properties such as gelling, thickening, and stabilizing abilities. It is particularly well-suited for the encapsulation of both solid and liquid drugs, making it a preferred choice for pharmaceutical companies developing treatments for chronic illnesses. Another important factor that drives the Pharmaceutical Gelatin market is an expansion of the pharmaceutical industry. The pharmaceutical industry fosters a conducive environment for the growth of pharmaceutical gelatin by driving demand for gelatin-based pharmaceutical dosage forms, encouraging innovation in drug delivery technologies, and expanding manufacturing capabilities across the world. In addition, as per the European Federation of Pharmaceutical Industries and Associations, in 2021 North America accounted for 49.1% of world pharmaceutical sales compared with 23.4% for Europe. Gelatin-based drug delivery systems, such as softgel capsules, microspheres, and nanoparticles, are gaining popularity due to their ability to enhance drug solubility, bioavailability, and controlled release profiles. Moreover, technological advancements in gelatin-based pharmaceuticals and increasing government healthcare expenditure are anticipated to create a lucrative growth opportunity for the market over the forecast period. However, the availability of alternative formulation ingredients and fluctuations in the prices of raw materials are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pharmaceutical Gelatin Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing approvals of prescription drug products in the region. Increased prescription medicine approvals indicate that the pharmaceutical sector is continuing to conduct research and development operations. This R&D frequently entails investigating drug formulations, combination medicines, and delivery technologies. Gelatin's features, such as biocompatibility, biodegradability, and ease of processing, make it an appealing choice for formulators seeking to innovate in drug development. According to the U.S. Food and Drug Administration, there are over 20,000 prescription drug products approved for marketing. In addition, as per the Health Policy Institute, more than 66% of all adults in the United States use prescription drugs. The region's dominant performance is anticipated to propel the overall demand for Pharmaceutical Gelatin. Furthermore, Asia Pacific is expected to grow fastest during the forecast period, owing to factors such as increasing healthcare expenditure in the region. Increased healthcare spending may result in the expansion of healthcare infrastructure, including hospitals, clinics, and pharmacies. This expansion can lead to a higher volume of drug production and consumption, consequently increasing the demand for pharmaceutical gelatin.

Major market players included in this report are:

• PB Leiner GmbH
• Tessenderlo Group
• Weishardt Holding GmbH & Co. KG
• Gelita AG
• LAPI Gelatine S.p.A.
• Croda International Plc
• Eastman Chemical Company
• Rousselot Inc.
• Gelnex Pharmaceuticals
• Norland Products Inc.

Recent Developments in the Market:

• In December 2023, Amneal Pharmaceuticals, Inc. and Strides Pharma Science Limited announced the addition of Icosapent ethyl acid soft gel capsules, a product based on VASCEPA. Icosapent ethyl acid soft gel capsules 0.5g and 1g are an ethyl ester of eicosapentaenoic acid (EPA) advised as an addition to diet to lower triglyceride levels in adult patients with severe hypertriglyceridemia. Thus, Soft gel capsules typically require pharmaceutical-grade gelatin for their casing which are anticipated to create lucrative opportunities for the manufacturers and suppliers

Global Pharmaceutical Gelatin Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Type, Application, Source, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

• Type A Gelatin
• Type B Gelatin

By Application

• Capsules and Softgel Capsules
• Coatings
• Parenteral Formulations
• Other Applications

By Source

• Bovine Gelatin
• Porcine Gelatin
• Other Sources

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Pharmaceutical Gelatin Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Pharmaceutical Gelatin Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3.Pharmaceutical Gelatin Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Pharmaceutical Gelatin Market, by Source, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Pharmaceutical Gelatin Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Pharmaceutical Gelatin Market Dynamics

• 3.1.Pharmaceutical Gelatin Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Growing Prevalence of Chronic Illnesses
    • 3.1.1.2.Expansion of Pharmaceutical Industry
  • 3.1.2.Market Challenges
    • 3.1.2.1.Availability of Alternative Formulation Ingredients
    • 3.1.2.2.Fluctuations in Prices of Raw Materials
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Technological Advancements in Gelatin-Based Pharmaceuticals
    • 3.1.3.2.Increasing Government Healthcare Expenditure

Chapter 4.Global Pharmaceutical Gelatin Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Pharmaceutical Gelatin Market, by Type

• 5.1.Market Snapshot
• 5.2.Global Pharmaceutical Gelatin Market by Type, Performance - Potential Analysis
• 5.3.Global Pharmaceutical Gelatin Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4.Pharmaceutical Gelatin Market, Sub Segment Analysis
  • 5.4.1.Type A Gelatin
  • 5.4.2.Type B Gelatin

Chapter 6.Global Pharmaceutical Gelatin Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Pharmaceutical Gelatin Market by Application, Performance - Potential Analysis
• 6.3.Global Pharmaceutical Gelatin Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Pharmaceutical Gelatin Market, Sub Segment Analysis
  • 6.4.1.Capsules and Softgel Capsules
  • 6.4.2.Coatings
  • 6.4.3.Parenteral Formulations
  • 6.4.4.Other Applications

Chapter 7.Global Pharmaceutical Gelatin Market, by Source

• 7.1.Market Snapshot
• 7.2.Global Pharmaceutical Gelatin Market by Source, Performance - Potential Analysis
• 7.3.Global Pharmaceutical Gelatin Market Estimates & Forecasts by Source 2020-2030 (USD Billion)
• 7.4.Pharmaceutical Gelatin Market, Sub Segment Analysis
  • 7.4.1.Bovine Gelatin
  • 7.4.2.Porcine Gelatin
  • 7.4.3.Other Sources

Chapter 8.Global Pharmaceutical Gelatin Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Pharmaceutical Gelatin Market, Regional Market Snapshot
• 8.4.North America Pharmaceutical Gelatin Market
  • 8.4.1.U.S. Pharmaceutical Gelatin Market
    • 8.4.1.1.Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.Source breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Pharmaceutical Gelatin Market
• 8.5.Europe Pharmaceutical Gelatin Market Snapshot
  • 8.5.1.U.K. Pharmaceutical Gelatin Market
  • 8.5.2.Germany Pharmaceutical Gelatin Market
  • 8.5.3.France Pharmaceutical Gelatin Market
  • 8.5.4.Spain Pharmaceutical Gelatin Market
  • 8.5.5.Italy Pharmaceutical Gelatin Market
  • 8.5.6.Rest of Europe Pharmaceutical Gelatin Market
• 8.6.Asia-Pacific Pharmaceutical Gelatin Market Snapshot
  • 8.6.1.China Pharmaceutical Gelatin Market
  • 8.6.2.India Pharmaceutical Gelatin Market
  • 8.6.3.Japan Pharmaceutical Gelatin Market
  • 8.6.4.Australia Pharmaceutical Gelatin Market
  • 8.6.5.South Korea Pharmaceutical Gelatin Market
  • 8.6.6.Rest of Asia Pacific Pharmaceutical Gelatin Market
• 8.7.Latin America Pharmaceutical Gelatin Market Snapshot
  • 8.7.1.Brazil Pharmaceutical Gelatin Market
  • 8.7.2.Mexico Pharmaceutical Gelatin Market
• 8.8.Middle East & Africa Pharmaceutical Gelatin Market
  • 8.8.1.Saudi Arabia Pharmaceutical Gelatin Market
  • 8.8.2.South Africa Pharmaceutical Gelatin Market
  • 8.8.3.Rest of Middle East & Africa Pharmaceutical Gelatin Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.PB Leiner GmbH
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Tessenderlo Group
  • 9.3.3.Weishardt Holding GmbH & Co. KG
  • 9.3.4.Gelita AG
  • 9.3.5.LAPI Gelatine S.p.A.
  • 9.3.6.Croda International Plc
  • 9.3.7.Eastman Chemical Company
  • 9.3.8.Rousselot Inc
  • 9.3.9.Gelnex Pharmaceuticals
  • 9.3.10.Norland Products Inc

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption